Clinical Trials Logo

Sweating clinical trials

View clinical trials related to Sweating.

Filter by:
  • None
  • Page 1

NCT ID: NCT05861219 Not yet recruiting - Sweating Clinical Trials

Alternative Haemodiafiltration in Summer Season for Chronic Kidney Disease Patients

Start date: June 21, 2023
Phase: N/A
Study type: Interventional

Hemodiafiltration is a renal replacement technique combining diffusion and convection to enhance solute removal. Post dialyser replacement fluid is administered to achieve the target fluid balance. The skin is the largest human organ playing an important role in thermal and Na regulation and skin blood flow is 8.5-10%of cardiac output .

NCT ID: NCT05586477 Completed - Allergic Rhinitis Clinical Trials

Diphenhydramine and Sweating

BENEXE2022
Start date: November 21, 2022
Phase: Phase 4
Study type: Interventional

In 2012, it was estimated that nearly 1 in 4 Canadians suffer from allergic rhinitis. To add, 78% of individuals working in predisposing environments are predicted to develop occupational rhinitis. Currently, the most popular treatment for rhinitis is antihistamine medication such as diphenhydramine, a first-generation antihistamine sold commercially as Benadryl®. Due it its anticholinergic effects, diphenhydramine has been suggested to impair the whole body sweating response during heat stress, potentially leaving consumers at an increased risk of heat-related illness. This randomized control trial approved by Health Canada will investigate whether ingesting extra strength diphenhydramine (50mg) will alter whole-body sweat losses during 60 minutes of exercise.

NCT ID: NCT00335478 Completed - Clinical trials for Unspecified Adult Solid Tumor, Protocol Specific

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

Start date: December 2006
Phase: Phase 2
Study type: Interventional

RATIONALE: Antibiotics, such as daptomycin, may control neutropenia, fever, and infection in patients with cancer. PURPOSE: This phase II trial is studying how well daptomycin works in treating neutropenia and fever in patients with cancer.